Announced Thu, 23 Jul · 14:26 IST
Trading window closed Jul 1 to Aug 1 for Q1 FY27 results
Compliance View source PDF
ALIVUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-3.0%1-day move
₹1140.90
prior close
—
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-3.0-0.5-3.0———————
Up moveDown movePending
AI summary
Alivus Life Sciences (formerly Glenmark Life Sciences) has closed its trading window for designated persons from July 1 to August 1, 2026. This is ahead of the board meeting on July 30, 2026 to consider and approve unaudited financial results for the quarter ended June 30, 2026. Filed under SEBI insider trading and LODR regulations as a routine compliance measure.
Likely market impact
Routine compliance. No material impact. Q1 FY27 results expected around July 30, 2026.